Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2022   65,739,053      
Beginning balance at Dec. 31, 2022 $ 83,219 $ 0 $ 314,884 $ (231,636) $ (29)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   1,526,242      
Issuance of common shares from stock option exercises 11,353   11,353    
Issuance of common shares from the employee stock purchase plan (in shares)   292,246      
Issuance of common shares from the employee stock purchase plan $ 1,329   1,329    
Vesting of restricted stock units (in shares)   2,782,008      
Common stock withheld related to net settlement of equity awards (in shares) (998,356) (998,356)      
Common stock withheld related to net settlement of equity awards $ (7,483)   (7,483)    
Stock-based compensation 16,576   16,576    
Foreign currency translation adjustments, net of tax (41)       (41)
Net unrealized gain (loss) on investments (35)       (35)
Net loss (23,992)     (23,992)  
Ending balance (in shares) at Sep. 30, 2023   69,341,193      
Ending balance at Sep. 30, 2023 80,926 $ 0 336,659 (255,628) (105)
Beginning balance (in shares) at Jun. 30, 2023   67,323,083      
Beginning balance at Jun. 30, 2023 75,392 $ 0 323,844 (248,483) 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   1,176,101      
Issuance of common shares from stock option exercises 10,732   10,732    
Issuance of common shares from the employee stock purchase plan (in shares)   157,910      
Issuance of common shares from the employee stock purchase plan $ 707   707    
Vesting of restricted stock units (in shares)   1,148,942      
Common stock withheld related to net settlement of equity awards (in shares) (464,843) (464,843)      
Common stock withheld related to net settlement of equity awards $ (4,811)   (4,811)    
Stock-based compensation 6,187   6,187    
Foreign currency translation adjustments, net of tax (153)       (153)
Net unrealized gain (loss) on investments 17       17
Net loss (7,145)     (7,145)  
Ending balance (in shares) at Sep. 30, 2023   69,341,193      
Ending balance at Sep. 30, 2023 $ 80,926 $ 0 336,659 (255,628) (105)
Beginning balance (in shares) at Dec. 31, 2023 70,116,357 70,116,357      
Beginning balance at Dec. 31, 2023 $ 78,957 $ 0 341,514 (262,667) 110
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 41,112 134,005      
Issuance of common shares from stock option exercises $ 550   550    
Issuance of common shares from the employee stock purchase plan (in shares)   220,042      
Issuance of common shares from the employee stock purchase plan $ 1,997   1,997    
Vesting of restricted stock units (in shares)   3,333,364      
Common stock withheld related to net settlement of equity awards (in shares) (1,286,087) (1,286,087)      
Common stock withheld related to net settlement of equity awards $ (13,883)   (13,883)    
Stock-based compensation 23,085   23,085    
Foreign currency translation adjustments, net of tax (254)       (254)
Net unrealized gain (loss) on investments 19       19
Net loss $ (21,635)     (21,635)  
Ending balance (in shares) at Sep. 30, 2024 72,517,681 72,517,681      
Ending balance at Sep. 30, 2024 $ 68,836 $ 0 353,263 (284,302) (125)
Beginning balance (in shares) at Jun. 30, 2024   71,682,267      
Beginning balance at Jun. 30, 2024 69,823 $ 0 348,532 (278,423) (286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   41,112      
Issuance of common shares from stock option exercises 193   193    
Issuance of common shares from the employee stock purchase plan (in shares)   106,083      
Issuance of common shares from the employee stock purchase plan $ 977   977    
Vesting of restricted stock units (in shares)   1,113,289      
Common stock withheld related to net settlement of equity awards (in shares) (425,070) (425,070)      
Common stock withheld related to net settlement of equity awards $ (4,461)   (4,461)    
Stock-based compensation 8,022   8,022    
Foreign currency translation adjustments, net of tax 55       55
Net unrealized gain (loss) on investments 106       106
Net loss $ (5,879)     (5,879)  
Ending balance (in shares) at Sep. 30, 2024 72,517,681 72,517,681      
Ending balance at Sep. 30, 2024 $ 68,836 $ 0 $ 353,263 $ (284,302) $ (125)